Loading...
Header Logo
Keywords
Last Name
Institution

Dr Andres Jaramillo

TitleCoordinator, Research and Training Portfolio
InstitutionCentro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM), Cali, Colombia
AddressCarrera 125 # 19-225
Cali
Colombia
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    For more than nine years I have been a member of the Scientific Direction team and have participated in diverse strategies to build research and research training capacity in CIDEIM and its collaborating institutions. Almost immediately after I joined CIDEIM I was trained in the TDR short course “Effective Project Planning and Evaluation in Biomedical Research (EPPE)” in February 2007. Subsequently, I was trained as a trainer in May 2007. Since then, I have led seven Skill-Building and two Train-The-Trainer courses, disseminating the TDR EPPE methodology in Quito, Ecuador; Bordeaux, France; Rio de Janeiro, Brazil; Bogota and Cali, Colombia. Additionally, I participated as a facilitator in the pilot of the Implementation Research course conducted in Accra, Ghana in 2013. I have worked in the permanent institutionalization of these project planning and evaluation tools and other research skill building courses within CIDEIM and participated in the organization of web-based courses and seminars offered through the research training program that CIDEIM and Yale University have established with national and regional doctoral programs in biomedical science through the Global Infectious Disease (GID) Research Training program supported by the USNIH Fogarty International Center. Currently, I coordinate the dissemination of training by CIDEIM as the Latin American Regional Training Centre supported by the WHO TDR programme.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Halpaap BM, Tucker JD, Mathanga D, Juban N, Awor P, Saravia NG, Han L, de Villiers K, Kitamura M, Cuervo LG, Peeling R, Reeder JC. Social innovation in global health: sparking location action. Lancet Glob Health. 2020 May; 8(5):e633-e634. PMID: 32353305.
      View in: PubMed
    2. Navas A, Fernández O, Gallego-Marín C, Castro MDM, Rosales-Chilama M, Murillo J, Cossio A, McMahon-Pratt D, Saravia NG, Gómez MA. Profiles of Local and Systemic Inflammation in the Outcome of Treatment of Human Cutaneous Leishmaniasis Caused by Leishmania (Viannia). Infect Immun. 2020 02 20; 88(3). PMID: 31818959.
      View in: PubMed
    3. Gómez L, Jaramillo A, Halpaap B, Launois P, Cuervo LG, Saravia NG. Building research capacity through "Planning for Success". PLoS Negl Trop Dis. 2019 08; 13(8):e0007426. PMID: 31369556.
      View in: PubMed
    4. Regli IB, Fernández OL, Martínez-Salazar B, Gómez MA, Saravia NG, Tacchini-Cottier F. Resistance of Leishmania (Viannia) Panamensis to Meglumine Antimoniate or Miltefosine Modulates Neutrophil Effector Functions. Front Immunol. 2018; 9:3040. PMID: 30622537.
      View in: PubMed
    5. Navarro A, Rubiano L, Arango JD, Rojas CA, Alexander N, Saravia NG, Aronoff-Spencer E. Developing mobile health applications for neglected tropical disease research. PLoS Negl Trop Dis. 2018 11; 12(11):e0006791. PMID: 30383809.
      View in: PubMed
    6. Kip AE, Castro MDM, Gomez MA, Cossio A, Schellens JHM, Beijnen JH, Saravia NG, Dorlo TPC. Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure-response relationships. J Antimicrob Chemother. 2018 08 01; 73(8):2104-2111. PMID: 29757380.
      View in: PubMed
    7. Tulloch-Reid MK, Saravia NG, Dennis RJ, Jaramillo A, Cuervo LG, Walker SP, Salicrup LA. Strengthening institutional capacity for equitable health research: lessons from Latin America and the Caribbean. BMJ. 2018 Jul 16; 362:k2456. PMID: 30012634.
      View in: PubMed
    8. Berger BA, Bartlett AH, Saravia NG, Galindo Sevilla N. Pathophysiology of Leishmania Infection during Pregnancy. Trends Parasitol. 2017 12; 33(12):935-946. PMID: 28988681.
      View in: PubMed
    9. Barrera MC, Rojas LJ, Weiss A, Fernandez O, McMahon-Pratt D, Saravia NG, Gomez MA. Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility. Acta Trop. 2017 Dec; 176:355-363. PMID: 28843396.
      View in: PubMed
    10. Martínez-Valencia AJ, Daza-Rivera CF, Rosales-Chilama M, Cossio A, Casadiego Rincón EJ, Desai MM, Saravia NG, Gómez MA. Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 Jul; 11(7):e0005713. PMID: 28704369.
      View in: PubMed
    11. Berger BA, Cossio A, Saravia NG, Castro MDM, Prada S, Bartlett AH, Pho MT. Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 04; 11(4):e0005459. PMID: 28384261.
      View in: PubMed
    12. Ehrlich AK, Fernández OL, Rodriguez-Pinto D, Castilho TM, Corral Caridad MJ, Goldsmith-Pestana K, Saravia NG, McMahon-Pratt D. Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection. Infect Immun. 2017 03; 85(3). PMID: 28052994.
      View in: PubMed
    13. Castro MD, Gomez MA, Kip AE, Cossio A, Ortiz E, Navas A, Dorlo TP, Saravia NG. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis. Antimicrob Agents Chemother. 2017 03; 61(3). PMID: 27956421.
      View in: PubMed
    14. Saldarriaga OA, Castellanos-Gonzalez A, Porrozzi R, Baldeviano GC, Lescano AG, de Los Santos MB, Fernandez OL, Saravia NG, Costa E, Melby PC, Travi BL. An Innovative Field-Applicable Molecular Test to Diagnose Cutaneous Leishmania Viannia spp. Infections. PLoS Negl Trop Dis. 2016 Apr; 10(4):e0004638. PMID: 27115155.
      View in: PubMed
    15. Rosales-Chilama M, Gongora RE, Valderrama L, Jojoa J, Alexander N, Rubiano LC, Cossio A, Adams ER, Saravia NG, Gomez MA. Parasitological Confirmation and Analysis of Leishmania Diversity in Asymptomatic and Subclinical Infection following Resolution of Cutaneous Leishmaniasis. PLoS Negl Trop Dis. 2015 Dec; 9(12):e0004273. PMID: 26659114.
      View in: PubMed
    16. Gonzalez-Fajardo L, Fernández OL, McMahon-Pratt D, Saravia NG. Ex vivo host and parasite response to antileishmanial drugs and immunomodulators. PLoS Negl Trop Dis. 2015 May; 9(5):e0003820. PMID: 26024228.
      View in: PubMed
    17. Moreno M, Ferro C, Rosales-Chilama M, Rubiano L, Delgado M, Cossio A, Gómez MA, Ocampo C, Saravia NG. First report of Warileya rotundipennis (Psychodidae: Phlebotominae) naturally infected with Leishmania (Viannia) in a focus of cutaneous leishmaniasis in Colombia. Acta Trop. 2015 Aug; 148:191-6. PMID: 25917717.
      View in: PubMed
    18. Adams ER, Gomez MA, Scheske L, Rios R, Marquez R, Cossio A, Albertini A, Schallig H, Saravia NG. Sensitive diagnosis of cutaneous leishmaniasis by lesion swab sampling coupled to qPCR. Parasitology. 2014 Dec; 141(14):1891-7. PMID: 25111885.
      View in: PubMed
    19. Fernández OL, Diaz-Toro Y, Ovalle C, Valderrama L, Muvdi S, Rodríguez I, Gomez MA, Saravia NG. Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia. PLoS Negl Trop Dis. 2014 May; 8(5):e2871. PMID: 24853871.
      View in: PubMed
    20. Navas A, Vargas DA, Freudzon M, McMahon-Pratt D, Saravia NG, Gómez MA. Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression. Infect Immun. 2014 Jul; 82(7):2872-80. PMID: 24752514.
      View in: PubMed
    21. Rodriguez-Pinto D, Saravia NG, McMahon-Pratt D. CD4 T cell activation by B cells in human Leishmania (Viannia) infection. BMC Infect Dis. 2014 Feb 25; 14:108. PMID: 24568275.
      View in: PubMed
    22. Gómez MA, Navas A, Márquez R, Rojas LJ, Vargas DA, Blanco VM, Koren R, Zilberstein D, Saravia NG. Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival. J Antimicrob Chemother. 2014 Jan; 69(1):139-49. PMID: 23975742.
      View in: PubMed
    23. Blanco VM, Cossio A, Martinez JD, Saravia NG. Clinical and epidemiologic profile of cutaneous leishmaniasis in Colombian children: considerations for local treatment. Am J Trop Med Hyg. 2013 Aug; 89(2):359-64. PMID: 23798581.
      View in: PubMed
    24. Zangger H, Ronet C, Desponds C, Kuhlmann FM, Robinson J, Hartley MA, Prevel F, Castiglioni P, Pratlong F, Bastien P, Müller N, Parmentier L, Saravia NG, Beverley SM, Fasel N. Detection of Leishmania RNA virus in Leishmania parasites. PLoS Negl Trop Dis. 2013; 7(1):e2006. PMID: 23326619.
      View in: PubMed
    25. Ramírez C, Díaz-Toro Y, Tellez J, Castilho TM, Rojas R, Ettinger NA, Tikhonova I, Alexander ND, Valderrama L, Hager J, Wilson ME, Lin A, Zhao H, Saravia NG, McMahon-Pratt D. Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response. PLoS Negl Trop Dis. 2012; 6(10):e1866. PMID: 23145196.
      View in: PubMed
    26. Rodriguez-Pinto D, Navas A, Blanco VM, Ramírez L, Garcerant D, Cruz A, Craft N, Saravia NG. Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species. PLoS Negl Trop Dis. 2012; 6(4):e1627. PMID: 22545172.
      View in: PubMed
    27. Fernández O, Diaz-Toro Y, Valderrama L, Ovalle C, Valderrama M, Castillo H, Perez M, Saravia NG. Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp. J Clin Microbiol. 2012 Jul; 50(7):2207-11. PMID: 22518860.
      View in: PubMed
    28. Walker J, Gongora R, Vasquez JJ, Drummelsmith J, Burchmore R, Roy G, Ouellette M, Gomez MA, Saravia NG. Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis. Mol Biochem Parasitol. 2012 Jun; 183(2):166-76. PMID: 22449941.
      View in: PubMed
    29. Santaella J, Ocampo CB, Saravia NG, Méndez F, Góngora R, Gomez MA, Munstermann LE, Quinnell RJ. Leishmania (Viannia) infection in the domestic dog in Chaparral, Colombia. Am J Trop Med Hyg. 2011 May; 84(5):674-80. PMID: 21540374.
      View in: PubMed
    30. Gallego C, Golenbock D, Gomez MA, Saravia NG. Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis. Infect Immun. 2011 Jul; 79(7):2871-9. PMID: 21518783.
      View in: PubMed
    31. Castilho TM, Goldsmith-Pestana K, Lozano C, Valderrama L, Saravia NG, McMahon-Pratt D. Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease. Eur J Immunol. 2010 Oct; 40(10):2816-29. PMID: 20827674.
      View in: PubMed
    32. Díaz YR, Rojas R, Valderrama L, Saravia NG. T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species. J Infect Dis. 2010 Aug 15; 202(3):406-15. PMID: 20583921.
      View in: PubMed
    33. Figueroa RA, Lozano LE, Romero IC, Cardona MT, Prager M, Pacheco R, Diaz YR, Tellez JA, Saravia NG. Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species. J Infect Dis. 2009 Aug 15; 200(4):638-46. PMID: 19569974.
      View in: PubMed
    Jaramillo's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _